Seattle Cancel Care Alliance (Data Collection Only) — Seattle, Washington

Seattle Cancel Care Alliance (Data Collection Only) is a clinical research site located in Seattle, Washington, United States 98109.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Seattle Cancel Care Alliance (Data Collection Only) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Multiple Myeloma, Hodgkin Disease, Non-Hodgkin Lymphoma.

Sponsors: Memorial Sloan Kettering Cancer Center.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Seattle

Browse all research sites in Washington · View every site in Seattle

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Seattle Cancel Care Alliance (Data Collection Only)?

Seattle Cancel Care Alliance (Data Collection Only) has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Seattle Cancel Care Alliance (Data Collection Only) conducted?

Seattle Cancel Care Alliance (Data Collection Only) has 1 clinical trials on record, with 1 currently active. Their work covers Multiple Myeloma, Hodgkin Disease, Non-Hodgkin Lymphoma.

Is Seattle Cancel Care Alliance (Data Collection Only) accredited by Crixeo Clinical Trials?

Seattle Cancel Care Alliance (Data Collection Only) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Seattle Cancel Care Alliance (Data Collection Only)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.